Taipei Medical University

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Yang CH
------>authors3_c=
------>paper_class1=1
------>Impact_Factor=1.719
------>paper_class3=2
------>paper_class2=1
------>vol=49
------>confirm_bywho=sheujr
------>insert_bywho=cjhuang
------>Jurnal_Rank=45.5
------>authors4_c=
------>comm_author=1
------>patent_EDate=None
------>authors5_c=
------>publish_day=1
------>paper_class2Letter=None
------>page2=476
------>medlineContent=
------>unit=E0106
------>insert_date=20081121
------>iam=5
------>update_date=None
------>author=???
------>change_event=4
------>ISSN=
------>authors_c=
------>score=500
------>journal_name=Acta Anaesthesiologica Scandinavica
------>paper_name=NF-kappaB inhibitors stabilize the mRNA of high-affinity type-2 cationic amino acid transporter in LPS-stimulated rat liver
------>confirm_date=20081124
------>tch_id=093110
------>pmid=15777294
------>page1=468
------>fullAbstract=BACKGROUND: Induction of inducible nitric oxide synthase (iNOS) results in nitric oxide (NO) overproduction during endotoxemia. Cellular uptake of L-arginine, modulated by the isozymes of type-2 cationic amino acid transporters (CAT), including CAT-2, CAT-2A and CAT-2B, has been reported to be a crucial factor in the regulation of iNOS activity. We sought to elucidate the expression of CAT-2 isozymes and the role of nuclear factor-kappaB (NF-kappaB) in this expression in lipopolysaccharide (LPS)-treated rat liver. METHODS: Adult male Sprague-Dawley rats were randomly given intravenous (i.v.) injections of normal saline (N/S), LPS, LPS preceded by an NF-kappaB inhibitor (PDTC, dexamethasone or salicylate) or an NF-kappaB inhibitor alone. After injection, rats were sacrificed at different times and enzyme expression and liver injury were examined. Hepatic and systemic NO production were also measured. RESULTS: CAT-2, CAT-2A and CAT-2B were constitutively expressed in un-stimulated rat liver. LPS stimulation not only significantly increased iNOS mRNA and NO concentrations but also decreased the mRNA concentrations of CAT-2 and CAT-2B, but not CAT-2A, in a time-dependent manner. LPS-induced hepatic and systemic NO overproduction was associated with hepatocellular injury. Pre-treatment with NF-kappaB inhibitors significantly attenuated LPS-induced iNOS induction as well as CAT-2/CAT-2B mRNA destabilization, which was associated with significant inhibition of NO biosynthesis and less liver injury. CONCLUSION: NF-kappaB inhibitors stabilize CAT-2 and CAT-2B mRNA in LPS-stimulated rat liver. The hepatic CAT-2/CAT-2B pathway may be a constitutive part of cytoprotective mechanisms against sepsis.
------>tmu_sno=None
------>sno=19727
------>authors2=Tsai PS
------>authors3=Lee JJ
------>authors4=Huang CH
------>authors5=Huang CJ
------>authors6=
------>authors6_c=
------>authors=Yang CH
------>delete_flag=0
------>SCI_JNo=None
------>authors2_c=
------>publish_area=0
------>updateTitle=NF-kappaB inhibitors stabilize the mRNA of high-affinity type-2 cationic amino acid transporter in LPS-stimulated rat liver.
------>language=2
------>check_flag=None
------>submit_date=None
------>country=None
------>no=4
------>patent_SDate=None
------>update_bywho=None
------>publish_year=2005
------>submit_flag=None
------>publish_month=4
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z